share_log

S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

S-3/A：特定交易註冊聲明(修正)
美股SEC公告 ·  08/16 16:35

Moomoo AI 已提取核心訊息

SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.
SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.
SeaStar Medical控股公司(SeaStar Medical)於2024年8月16日向證券交易委員會(SEC)提交了S-3表格的修正案。該修正案涉及根據1933年證券法所進行的註冊聲明，以出售證券持有人的1,014,219股普通股。這些股票與SeaStar Medical發行的某些認股權有關。公司將不會從出售證券持有人出售的股票中獲得收益，但除非以現金方式行使，否則將獲得認股權行使價格。出售證券持有人可以通過不同的方式出售股票，包括在交易所、場外市場或通過私人交易進行。公司已同意承擔與股份註冊有關的費用，估計爲45,750美元。註冊允許出售證券持有人在招股書日期後的任何時間出售其股票，而交易將受制於包括SEC規則和法規在內的各種條件。
SeaStar Medical控股公司(SeaStar Medical)於2024年8月16日向證券交易委員會(SEC)提交了S-3表格的修正案。該修正案涉及根據1933年證券法所進行的註冊聲明，以出售證券持有人的1,014,219股普通股。這些股票與SeaStar Medical發行的某些認股權有關。公司將不會從出售證券持有人出售的股票中獲得收益，但除非以現金方式行使，否則將獲得認股權行使價格。出售證券持有人可以通過不同的方式出售股票，包括在交易所、場外市場或通過私人交易進行。公司已同意承擔與股份註冊有關的費用，估計爲45,750美元。註冊允許出售證券持有人在招股書日期後的任何時間出售其股票，而交易將受制於包括SEC規則和法規在內的各種條件。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間